Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers

This publication has 20 references indexed in Scilit:

• Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue
  Head & Neck, 1998
• The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix
  British Journal of Cancer, 1997
• Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
  Head & Neck, 1997
• Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix
  British Journal of Cancer, 1993
• Carcinoma of the tonsillar region: A multivariate analysis of 243 patients treated with radical radiotherapy
  Head & Neck, 1993
• Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
  New England Journal of Medicine, 1991
• Comparison between in vitro radiosensitivity and in vivo radioresponse of murine tumor cell lines I: parameters of in vitro radiosensitivity and endogenous cellular glutathione levels
  International Journal of Radiation Oncology*Biology*Physics, 1990
• The effect, of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: A theoretical evaluation
  International Journal of Radiation Oncology*Biology*Physics, 1989
• The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve
  Radiotherapy and Oncology, 1984
• Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1981